We are live on
!
Find out more
GT
Greenleaf Trust Portfolio holdings
AUM
$10.4B
1-Year Est. Return
0.97%
This Fund
S&P 500
1 Year Est. Return
+0.97%
AUM
$10.4B
AUM Growth
+$210M
(+2.1%)
Holding
910
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$52M | |
| 2 | +$12.7M | |
| 3 | +$9.89M | |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$8.15M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$224M | |
| 2 | +$38.3M | |
| 3 | +$12.9M | |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.71M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$6.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.87% |
| 2 | Technology | 8.1% |
| 3 | Financials | 3.93% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.27% |
Similar funds
ECU
CMTU
RWP
TIM
AAM
PCIA
BSL
LWCFA
Greenleaf Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Greenleaf Trust held 910 positions worth $10.4B, up 2.1% from $10.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Greenleaf Trust's Q2 2026 filing shows 106 new, 328 increased, 392 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 12,478 shares worth $2.37M. The largest sale was Stryker, an estimated $224M.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
- Greenleaf Trust's largest Q2 2026 buy was AstraZeneca: 12,478 shares worth $2.37M.
- Greenleaf Trust added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $52M increase.
- Greenleaf Trust's biggest Q2 2026 reduction was Stryker, cutting an estimated $224M.
- Greenleaf Trust fully exited Liquidia Corp in Q2 2026, selling an estimated $529K.
- Greenleaf Trust's ten largest holdings make up 71% of its $10.4B portfolio in Q2 2026.
- Greenleaf Trust opened 106 new positions and closed 43 in Q2 2026.
- Greenleaf Trust's portfolio value rose 2.1% quarter-over-quarter to $10.4B.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.